In: Basic Research in Cardiology, 2007, vol. 102, no. 4, p. 308-317
|
In: Medical Oncology, 1999, vol. 16, no. 2, p. 78-85
|
In: Basic Research in Cardiology, 2005, vol. 100, no. 2, p. 102-111
|
In: Annals of Oncology, 1998, vol. 9, no. 6, p. 589-600
|
In: Basic Research in Cardiology, 2005, vol. 100(2), p. 102
Nitric oxide (NO) and monocyte chemoattractant protein–1 (MCP-1) exert partly opposing effects in vascular biology. NO plays pleiotropic vasoprotective roles including vasodilation and inhibition of platelet aggregation, smooth muscle cell proliferation, and endothelial monocyte adhesion, the last effect being mediated by MCP–1 downregulation. Early stages of arteriosclerosis are associated...
|